Evaluation of the flow cytometric crossmatch - Preliminary results of a multicenter study

被引:12
作者
Harmer, AW
Garner, S
Bell, AE
Anyanwu, C
Cavanagh, G
Culkin, J
Evans, PR
Horsburgh, T
Martin, S
McCloskey, D
Reynolds, WM
Robson, A
Sutton, M
vanDam, MG
Shenton, BK
机构
[1] N LONDON BLOOD TRANSFUS CTR,LONDON NW9 5BG,ENGLAND
[2] UNIV NEWCASTLE UPON TYNE,SCH MED,DEPT SURG,NEWCASTLE TYNE NE2 4HH,TYNE & WEAR,ENGLAND
[3] ST MARYS HOSP,TISSUE TYPING LAB,MANCHESTER M13 0HJ,LANCS,ENGLAND
[4] OXFORD TRANSPLANT CTR,TISSUE TYPING LAB,OXFORD OX3 7LJ,ENGLAND
[5] ST MARYS HOSP,TISSUE TYPING LAB,LONDON W2 1NY,ENGLAND
[6] ROYAL LIVERPOOL UNIV HOSP,DEPT IMMUNOL,LIVERPOOL L7 8XP,MERSEYSIDE,ENGLAND
[7] SOUTHAMPTON UNIV HOSP,WESSEX IMMUNOL SERV,SOUTHAMPTON SO16 6YD,HANTS,ENGLAND
[8] LEICESTER GEN HOSP,DEPT SURG,LEICESTER LE5 4PW,LEICS,ENGLAND
[9] UNIV LONDON LONDON HOSP,COLL MED,DEPT IMMUNOL,LONDON E1 2AD,ENGLAND
[10] BLOOD TRANSFUS SERV,TISSUE TYPING LAB,NEWCASTLE TYNE NE2 4NQ,TYNE & WEAR,ENGLAND
[11] REG TRANSFUS CTR,TISSUE TYPING LAB,BIRMINGHAM B15 2SG,W MIDLANDS,ENGLAND
关键词
D O I
10.1097/00007890-199604150-00021
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The flow cytometric crossmatch is a technique that is increasingly being used by clinical transplant laboratories. In this multicenter study by the British Society for Histocompatibility and Immunogenetics Flow Cytometry Group, a series of crossmatches were carried out to determine whether different centers obtained the same results when performing the same crossmatch. There was greater than 80% agreement among participating laboratories on the results of 34/54 tests. There was no clear agreement in the remaining 20 cases. Quantitative analysis, estimating the number of cell-bound fluorescein molecules, demonstrated that differences in the criteria used by each center to define a positive crossmatch were responsible for some of the discordant results. When applied, definition of positivity based on molecules of fluorescein increased concordance from 57.5% to 81.4%. These results suggest that a criterion for the interpretation of results based on quantitative analysis of bound antibody may be more reliable than methods in current routine use.
引用
收藏
页码:1108 / 1111
页数:4
相关论文
共 9 条
[1]  
COOK DJ, 1987, CLIN TRANSPLANT, V1, P253
[2]  
EVANS PR, 1992, TRANSPLANT INT, V5, pS609
[3]   IMPROVED GRAFT-SURVIVAL FOR FLOW-CYTOMETRY AND ANTIHUMAN GLOBULIN CROSSMATCH-NEGATIVE RETRANSPLANT RECIPIENTS [J].
KERMAN, RH ;
VANBUREN, CT ;
LEWIS, RM ;
DEVERA, V ;
BAGHDAHSARIAN, V ;
GEROLAMI, K ;
KAHAN, BD .
TRANSPLANTATION, 1990, 49 (01) :52-56
[4]   THE RELATIONSHIP BETWEEN FLOW CYTOMETER CROSSMATCH RESULTS AND SUBSEQUENT REJECTION EPISODES IN CADAVER RENAL-ALLOGRAFT RECIPIENTS [J].
LAZDA, VA ;
POLLAK, R ;
MOZES, MF ;
JONASSON, O .
TRANSPLANTATION, 1988, 45 (03) :562-565
[5]  
Martin S, 1993, Transpl Immunol, V1, P270, DOI 10.1016/0966-3274(93)90035-7
[6]  
OGURA K, 1993, TRANSPLANTATION, V56, P294
[7]  
SCORNIK JC, 1994, TRANSPLANTATION, V57, P621
[8]  
TALBOT D, 1990, TRANSPLANTATION, V49, P809
[9]   IMPROVED GRAFT OUTCOME AND REDUCED COMPLICATIONS DUE TO FLOW CYTOMETRIC CROSS-MATCHING AND DR MATCHING IN RENAL-TRANSPLANTATION [J].
TALBOT, D ;
CAVANAGH, G ;
COATES, E ;
GIVAN, AL ;
SHENTON, BK ;
LENNARD, TWJ ;
PROUD, G ;
TAYLOR, RMR .
TRANSPLANTATION, 1992, 53 (04) :925-928